Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanna Liuzzo

Showing results (1-10 of 271) with videos related to

Pageof 28
Sort By:
European Heart Journal|December 10, 2024
Weekly Journal Scan: An EPIC comparison of edoxaban vs. dual antithrombotic therapy in atrial fibrillation and stable coronary artery diseaseGiovanna Liuzzo, Carlo Patrono
European Heart Journal|September 8, 2023
Silencing liver angiotensinogen synthesis as a novel approach to hypertension management: promises and challengesGiovanna Liuzzo, Massimo Volpe
European Heart Journal|June 3, 2021
Unhealthy lifestyles mediate only a small proportion of the socioeconomic inequalities' impact on cardiovascular outcomes in US and UK adults: a call for action for social cardiologyGiovanna Liuzzo, Massimo Volpe
European Heart Journal|February 16, 2024
Weekly journal scan: SURMOUNTing body weight regain with tirzepatide after successful lifestyle interventionGiovanna Liuzzo, Carlo Patrono
European Heart Journal|April 1, 2024
Weekly journal scan: the KCa2 potassium channel as a promising target for the pharmacologic cardioversion of atrial fibrillationGiovanna Liuzzo, Daniela Pedicino
European Heart Journal|April 3, 2024
Weekly journal scan: it takes two for acute strokeGiovanna Liuzzo, Carlo Patrono
European Heart Journal|October 7, 2020
EMPEROR-Reduced supports the use of SGLT2 inhibitors for the treatment of patients with heart failure and reduced ejection fraction: Comment on the EMPEROR-Reduced trialGiovanna Liuzzo, Carlo Patrono
Circulation|March 14, 2018
Addressing Acute Coronary Syndromes: New Challenges and Opportunities After the CANTOS Trial (Canakinumab Anti-inflammatory Thrombosis Outcomes Study)Filippo Crea, Giovanna Liuzzo
European Heart Journal|December 14, 2021
FIGARO-DKD adds new evidence to the cardiovascular benefits of finerenone across the spectrum of patients with type 2 diabetes and chronic kidney diseaseGiovanna Liuzzo, Massimo Volpe
European Heart Journal|October 10, 2022
Mind the map: a multi-omic approach to post-ischaemic cardiac remodelling paves the way for future cardiovascular researchDaniela Pedicino, Giovanna Liuzzo
Pageof 28

Showing results (1-10 of 271) with videos related to

Sort By:
Pageof 28
European Heart Journal|December 10, 2024
Weekly Journal Scan: An EPIC comparison of edoxaban vs. dual antithrombotic therapy in atrial fibrillation and stable coronary artery diseaseGiovanna Liuzzo, Carlo Patrono
European Heart Journal|September 8, 2023
Silencing liver angiotensinogen synthesis as a novel approach to hypertension management: promises and challengesGiovanna Liuzzo, Massimo Volpe
European Heart Journal|June 3, 2021
Unhealthy lifestyles mediate only a small proportion of the socioeconomic inequalities' impact on cardiovascular outcomes in US and UK adults: a call for action for social cardiologyGiovanna Liuzzo, Massimo Volpe
European Heart Journal|February 16, 2024
Weekly journal scan: SURMOUNTing body weight regain with tirzepatide after successful lifestyle interventionGiovanna Liuzzo, Carlo Patrono
European Heart Journal|April 1, 2024
Weekly journal scan: the KCa2 potassium channel as a promising target for the pharmacologic cardioversion of atrial fibrillationGiovanna Liuzzo, Daniela Pedicino
European Heart Journal|April 3, 2024
Weekly journal scan: it takes two for acute strokeGiovanna Liuzzo, Carlo Patrono
European Heart Journal|October 7, 2020
EMPEROR-Reduced supports the use of SGLT2 inhibitors for the treatment of patients with heart failure and reduced ejection fraction: Comment on the EMPEROR-Reduced trialGiovanna Liuzzo, Carlo Patrono
Circulation|March 14, 2018
Addressing Acute Coronary Syndromes: New Challenges and Opportunities After the CANTOS Trial (Canakinumab Anti-inflammatory Thrombosis Outcomes Study)Filippo Crea, Giovanna Liuzzo
European Heart Journal|December 14, 2021
FIGARO-DKD adds new evidence to the cardiovascular benefits of finerenone across the spectrum of patients with type 2 diabetes and chronic kidney diseaseGiovanna Liuzzo, Massimo Volpe
European Heart Journal|October 10, 2022
Mind the map: a multi-omic approach to post-ischaemic cardiac remodelling paves the way for future cardiovascular researchDaniela Pedicino, Giovanna Liuzzo
Pageof 28